Skip to content
value.today

Nohla Therapeutics Inc.

🇺🇸 Seattle, Washington, USABiotechnologyFounded 2015

Formerly Cytomatrix Therapeutics, Inc.

Total raised
$79 M
3 rounds on record
Latest round
$45 M
May 2018
First round on record
Dec 2015
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Nohla Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2018$45 MNo. 3$10 to $50 million

Nohla Therapeutics Inc.: Raise no. 3, May 2018

Investors in this round

10 investors had bought by the notice of May 16, 2018: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$45 M of $58 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Colleen Delaney · Executive Officer
  • Gary Christianson · Executive Officer
  • Jim Johnson · Executive Officer
  • Kathleen Fanning · Executive Officer, Director
  • Brian Daniels · Director
  • Lawrence Gozlan · Director
  • Michael Sistenich · Director
  • Steven Gillis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “These amounts exclude issuances of Company securities pursuant to Regulation S promulgated under the Securities Act of 1933, as amended.”

Signed by Tom Swallow, Vice President, Finance & Administration. Newest notice filed May 16, 2018. Read the notice at the SEC.

equitySEC
Nov 2016$32 MNo. 2$10 to $50 million

Nohla Therapeutics Inc.: Raise no. 2, Nov 2016

Investors in this round

13 investors had bought by the notice of Nov 16, 2017: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $42 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kathleen Fanning · Executive Officer, Director
  • Brian Daniels · Director
  • Lawrence Gozlan · Director
  • Michael Sistenich · Director
  • Steven Gillis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “These amounts exclude issuances of Company securities pursuant to Regulation S promulgated under the Securities Act of 1933, as amended”

Signed by Tom Swallow, Vice President, Finance & Administration. Newest notice filed Nov 16, 2017 (1 amendment). Read the notice at the SEC.

equitySEC
Dec 2015$2 MNo. 1$2 to $10 million

Nohla Therapeutics Inc.: Raise no. 1, Dec 2015

Investors in this round

9 investors had bought by the notice of Dec 29, 2015: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Benjamin Scot Bergo · Executive Officer, Director, Promoter
  • Darren David Scotti · Executive Officer
  • Ian David Brown · Director
  • Lawrence David Gozlan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Company offered and sold securities totaling $21,149,994 in the financing. The offer and sale of the remaining securities was exempt from registration pursuant to Regulation S promulgated under the Securities Act of 1933, as amended.”

Signed by Darren Scotti, Secretary. Newest notice filed Dec 29, 2015. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Nohla Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (May 2018).

    SEC Form D · May 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2018

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Nohla Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Nohla Therapeutics Inc.
NameRoleNamed in
Colleen DelaneyExecutive officerMay 2018
Gary ChristiansonExecutive officerMay 2018
Jim JohnsonExecutive officerMay 2018
Kathleen FanningExecutive officerMay 2018
Darren ScottiExecutive officerDec 2016
Michael SistenichExecutive officerDec 2016
Benjamin Scot BergoExecutive officerDec 2015
Darren David ScottiExecutive officerDec 2015
Brian DanielsDirectorMay 2018
Kathleen FanningDirectorMay 2018
Lawrence GozlanDirectorMay 2018
Michael SistenichDirectorMay 2018
Steven GillisDirectorMay 2018
Benjamin Scot BergoDirectorDec 2015
Ian David BrownDirectorDec 2015
Lawrence David GozlanDirectorDec 2015
Benjamin Scot BergoPromoterDec 2015